Friday, March 31, 2017
This Is Really Important News For Those Hoping To Improve Information Access And Interoperability.
This appeared last week.
Published March 23 2017, 7:15am EDT
Health Level 7 International has published Release 3 of its Fast Healthcare Interoperability Resources Standard for Trial Use (STU), moving it closer to a normative version of FHIR.
According to HL7, FHIR STU 3 is the “culmination of 18 months of extensive work to incorporate changes and enhancement requests received from implementation partners across the world” including the Argonaut Project, an industry-wide effort to accelerate the development and adoption of the emerging standards framework.
“Release 3 represents a significant milestone for HL7 FHIR, demonstrating the continued evolution of the FHIR platform and a promise for interoperability, which it represents,” says HL7’s CEO Chuck Jaffe, MD. “It is a tribute to the hundreds of individuals worldwide who have contributed to the standard’s development and thousands to its implementation.”
Among the enhancements to FHIR STU 3 are support for clinical decision support and clinical quality measures, broadened functionality to cover key clinical workflows, as well as further development of terminology services and support for financial management.
“This is a significant milestone, requiring thousands of person hours of volunteer time. People should begin using the new version of the standard as soon as possible,” says Stan Huff, MD, chief medical informatics officer at Intermountain Healthcare.
“At the Argonaut Project, we are especially excited about this release because it will allow us to publish our Argonaut Project Provider Directory Implementation Guide, which is based on resources contained in FHIR Release 3, and will assist any organization seeking to implement a provider directory based on modern standards,” adds Micky Tripathi, project manager of the Argonaut Project.
Lots more here:
This is really good news as we gradually make health information more accessible and shareable.
Well done to the team!
Posted by Dr David More MB PhD FACHI at Friday, March 31, 2017